SAN DIEGO, CA–(Marketwired – October 13, 2015) – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive and procedurally integrated solutions, today announced that it will attend the North American Spine Society (NASS) 30th Annual
All News
LEESBURG, Va., Oct. 13, 2015 (GLOBE NEWSWIRE) — K2M Group Holdings, Inc. (Nasdaq:KTWO), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it will introduce Lamellar Titanium Technology™,
MEQUON, Wis.–(BUSINESS WIRE)–Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that a new biomechanical study demonstrates that titanium coated polyetheretherketone (PEEK) implants are susceptible to the generation of particulate debris
NOBLESVILLE, Ind.–(BUSINESS WIRE)–Nexxt Spine, LLC, a privately held medical device company dedicated to increasing procedural efficiency and patient outcomes for patients with debilitating spinal conditions today announced major milestones illustrating the company’s growth and momentum. Nexxt Spine President Andy Elsbury,
CHARLOTTE, NC (PRWEB) OCTOBER 11, 2015 Intelligent Implant Systems, LLC is pleased to announce today that Revolution™ Spinal System has been officially launched and multiple surgeries have been completed with this new posterior thoracolumbar spinal fusion system. The surgeries were performed
LEUVEN, Belgium, Oct. 12, 2015 (GLOBE NEWSWIRE) — Materialise NV (Nasdaq:MTLS), a leading provider of 3D software and sophisticated 3D printing solutions, and pioneer in medical image based knee guide technology, today announced that Global will use its Knee Guide System. The Materialise
Bioventus Launches SUPARTZ FX™Now with Expanded Safety Label for Repeat Injection Cycles in Knee Osteoarthritis DURHAM, NC – October 12, 2015 – Bioventus, a global leader in orthobiologics, today announced the launch of SUPARTZ FX™, a broadening of its current
HAIFA, Israel, Oct. 12, 2015 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced it has expanded its five-year Collaborative Research Agreement with the Berlin-Brandenburg Center for Regenerative Therapy at Charité – University Medicine
By Samantha Reynolds Wright Medical Group (NASDAQ:WMGI) had its price target decreased by BMO Capital Markets from $30.00 to $26.00 in a research report report published on Friday, StockTargetPrices.com reports. Other equities research analysts also recently issued reports about the company. Brean Capital reiterated a buy rating
By Jennifer Bresnick By combining historical immigration and socioeconomic data with information found in modern electronic health records, researchers at the Icahn School of Medicine at Mount Sinai (ISMMS) are taking a unique look at population health management and precision medicine during
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1